References
- White PC, Speiser PW. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocr Rev. 2000;21:245-291.
- Ginalska-Malinowska M. Wrodzony przerost nadnerczy u dzieci i młodzieży – diagnostyka i leczenie. Pediatr Dypl. 2012;16:18-25.
- Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HFL, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4133-4160.
- Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW. Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology. J Clin Endocrinol Metab. 2002;87:4048-4053.
- Romanowska H, Krzywińska-Zdeb E, Walczak M, Giżewska M. Wrodzony przerost nadnerczy u noworodka. Pediatr Dypl. 2017;21:25-31.
- Ballerini MG, Chiesa A, Scaglia P, Gruñeiro-Papendieck L, Heinrich JJ, Ropelato MG. 17alpha-hydroxyprogesterone and cortisol serum in neonates and young children: influence of age, gender and methodological procedures. J Pediatr Endocrinol Metab. 2010;23:121-132.
- Pang SY, Wallace MA, Hofman L, Thuline HC, Doche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81:866-874.
- White PC. Optimizing Newborn Screening for Congenital Adrenal Hyperplasia. J Pediatr. 2013;163:10-12.